| Effects of Vitamin D on Gut Microbiota, Intestinal Barrier in IBS-D Patients (NCT05593367) | Second Affiliated Hospital of Xi'an Jiaotong University | 2022-02-01 |
| Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D (NCT05369884) | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 2021-12-01 |
| Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) (NCT03977155) | Boston Pharmaceuticals | 2019-06-04 |
| Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D (NCT03099785) | Cosmo Technologies Ltd | 2017-12-18 |
| Allogeneic Microbiota-reconstitution (AMR) in Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) (NCT04095988) | University of Ulm | 2016-09-01 |
| Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome (NCT02538692) | Chengdu University of Traditional Chinese Medicine | 2015-12-01 |
| Special Drug Use Surveillance of Irribow in Female Patients (NCT02612649) | Astellas Pharma Inc | 2015-10-01 |
| Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome (NCT02190526) | Tehran University of Medical Sciences | 2014-09-01 |
| Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth (NCT02251483) | Cedars-Sinai Medical Center | 2014-09-01 |
| Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D (NCT02239926) | Mayo Clinic | 2014-09-01 |
| Safety and Tolerability of Serum Derived Bovine Immunoglobulin in Children With Diarrhea Predominant IBS (NCT02358694) | Connecticut Children's Medical Center | 2014-06-15 |
| Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Bid on Nutritional Status in Subjects With IBS-D (NCT02163213) | Mayo Clinic | 2014-06-01 |
| Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile Acids (NCT02111603) | Mayo Clinic | 2014-04-01 |
| A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) (NCT01896583) | Seldar Pharma, Inc. | 2013-11-01 |
| A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS) (NCT01870895) | Astellas Pharma Inc | 2013-02-01 |
| A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (NCT01736423) | Astellas Pharma Inc | 2012-09-01 |
| The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel Syndrome (NCT01637714) | Seoul National University Hospital | 2012-07-01 |
| Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial (NCT01350570) | Chengdu University of Traditional Chinese Medicine | 2011-08-01 |
| The Effects of Soy Dietary Fiber in Adults With Diarrhea Predominant Irritable Bowel Syndrome (NCT01373034) | Seoul National University Hospital | 2011-07-01 |
| Glutamine for the Treatment of Patients With Irritable Bowel Syndrome (NCT01414244) | Tulane University | 2010-11-01 |
| Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg (NCT01358708) | Forest Laboratories | 2010-06-01 |
| Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) (NCT01100684) | Tioga Pharmaceuticals | 2010-05-01 |
| Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome (NCT01094041) | Mayo Clinic | 2010-02-01 |
| Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS) (NCT00616200) | University of North Carolina, Chapel Hill | 2009-08-01 |